Compounded GLP-1 formulations, which may be used for microdosing, carry additional risks, including uncertain drug quality and imprecise dosing that may be especially dangerous for people who also take insulin
J Am Coll Cardiol 2021;77:2366-77.ArticlePubMed 687
Kadowaki, T., Isendahl, J., Khalid, U., Lee, S
On the other hand, it is well established that low-grade inflammation promotes the development of insulin resistance and the progression of T2D [58]
These effects may potentially provide a novel therapeutic solution for stroke, imparting specific beneficial effects on the CNS (i.e., for reperfusion, the amelioration of neuronal damage and, thereby, recovery without memory, locomotor, and coordination disturbances, and the expression of the particular genes in the hippocampus)